Evidence map›Paper›PMID 33352722›Full record

ArticleCancers2020

3'RNA Sequencing Accurately Classifies Formalin-Fixed Paraffin-Embedded Uterine Leiomyomas.

Miika Mehine, Sara Khamaiseh, Terhi Ahvenainen, Tuomas Heikkinen, Anna Äyräväinen, Päivi Pakarinen, Päivi Härkki, Annukka Pasanen, Ralf Bützow, Pia Vahteristo

Abstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Uterine leiomyoma with RAD51B::NUDT3 fusion: a report of 2 cases.Virchows Archiv : an international journal of pathology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. LncRNAInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miika MehineApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0003-0443-0625
Sara KhamaisehApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.
Terhi AhvenainenApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.
Tuomas HeikkinenApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.
Anna ÄyräväinenApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.
Päivi PakarinenDepartment of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, 00029 Helsinki, Finland.ORCID 0000-0002-1275-7356
Päivi HärkkiDepartment of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, 00029 Helsinki, Finland.
Annukka PasanenApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-0079-9807
Ralf BützowApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.
Pia VahteristoApplied Tumor Genomics Research Program, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-4615-3825

Funding

Academy of Finland 307773iCAN Digital Precision Cancer Medicine Flagship -Sigrid Juséliuksen Säätiö -Syöpäsäätiö -
6 · The paper itself

Abstract

Uterine leiomyomas are benign smooth muscle tumors occurring in 70% of women of reproductive age. The majority of leiomyomas harbor one of three well-established genetic changes: a hotspot mutation in

Indexed as

3′RNA sequencingFFPEFHfibroidsHMGA2MED12QuantSeq

Identifiers

PMID33352722
PMCPMC7766537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.